News, Short Squeeze, Breakout and More Instantly...
IGM Biosciences Inc. Company Name:
IGMS Stock Symbol:
NYSE Market:
- Enrollment target exceeded in aplitabart randomized colorectal cancer clinical trial - - Enrollment completed in first dose cohort in imvotamab rheumatoid arthritis clinical trial - MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a c...
MOUNTAIN VIEW, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that management will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conferenc...
Investors might want to bet on IGM Biosciences, Inc. (NASDAQ: IGMS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in ...